Back to 
LMR Partners LLP
LMR Partners LLP
XERS
Showing 0 of 2 quarters
Position history for LMR Partners LLP's holdings in XERIS BIOPHARMA HOLDINGS INC
No. LMR Partners exited its XERS (Xeris Biopharma Holdings) position in Q2 2022. Its Q1 2022 13F listed 107,355 shares worth $275,000. LMR Partners first reported XERS in Q1 2022 and held it in 1 quarterly 13F filing.
Current Value
—
Current Shares
—
Total Value Change
$0
Total Shares Change
0
No position history available for this security.